Scientists hunt for clues in blood cancer samples to improve future treatments
NCT ID NCT07154823
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 4 times
Summary
This study is collecting blood, bone marrow, and leftover tissue samples from 550 people with acute myeloid leukemia or follicular lymphoma. Researchers will analyze the samples to find genetic markers that may predict how well treatments work or why some stop working. The goal is to better understand these blood cancers and guide future therapy decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKAEMIA (AML) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Avera Cancer Institue
RECRUITINGSioux Falls, South Dakota, 57105, United States
Contact Email: •••••@•••••
-
Cancer Care Associates of York
RECRUITINGYork, Pennsylvania, 17403, United States
-
Cancer Care Specialists of Reno
RECRUITINGReno, Nevada, 89511, United States
-
OhioHealth Research Institute
RECRUITINGColumbus, Ohio, 43214, United States
-
Taylor Cancer Research Center
RECRUITINGMaumee, Ohio, 43537, United States
-
The Center for Cancer and Blood Disorders
RECRUITINGBethesda, Maryland, 20817, United States
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45219, United States
-
University of Iowa Hospital and Clinics
RECRUITINGIowa City, Iowa, 52242, United States
-
Washington University in St. Louis
RECRUITINGSt Louis, Missouri, 63130, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug cocktail replace chemo for follicular lymphoma?
- New drug combo aims to outsmart recurring lymphoma
- New hope for AML patients: experimental drug IPN60340 enters key trial
- New combo pill attack aims to control blood cancers
- Smart blood pressure cuffs could protect cancer patients from heart risks
- New cell therapy CT1182 takes on tough lymphoma